openPR Logo
Press release

Acute Agitation And Aggression Treatment Market Demand: Analysis, Outlook, and Trends 2024-2033

02-22-2024 11:20 AM CET | Health & Medicine

Press release from: The Business research company

Acute Agitation And Aggression Treatment Market

Acute Agitation And Aggression Treatment Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Acute Agitation And Aggression Treatment Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The acute agitation & aggression treatment market size has grown strongly in recent years. It will grow from $5.4 billion in 2023 to $5.72 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to advances in pharmacology, rise in clinical research, regulatory approvals, rise in prevalence of acute agitation and aggression cases, increased awareness regarding mental health .

The acute agitation & aggression treatment market size is expected to see strong growth in the next few years. It will grow to $7.23 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to growing aging population, growing healthcare infrastructure, rising pharmaceutical industry investment, rise in home-base care, rise in disposable income. Major trends in the forecast period include non-pharmacological interventions, precision medicine, ai and predictive analytics, community-based support, industry collaboration.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13078&type=smp

Market Segmentation:
The acute agitation and aggression treatment market market covered in this report is segmented -
1) By Treatment Approach: Behavioral Approaches, Environmental Interventions, Pharmacologic Approaches
2) By Drug Class: Anti-Psychotics, Benzodiazepines, Other Drug Classes
3) By Route of Administration: Oral, Intramuscular, Other Routes of Administrations
4) By Indication: Schizophrenia, Dementia, Bipolar Disorder, Depression, Drug-Induced Agitation And Aggression, Alcohol Withdrawal, Other Indications
5) By End User: Hospitals And Ambulatory Surgical Centers, Psychiatric Care Facilities, Other End Users

Major Driver - Rising Dementia Incidence Fuels Growth In Acute Agitation And Aggression Treatment Market
The increase in the incidence of dementia is expected to propel the growth of the acute agitation and aggression treatment market going forward. Dementia refers to conditions characterized by impaired memory, cognition, and the capability to manage everyday tasks. A symptom often observed in dementia patients is agitation, manifested through behaviors such as restlessness, repetitive actions, or frequent hand movements. Acute agitation and aggression treatment play a key role in dementia. It reduces the risk of harmful symptoms, improves the patient's quality of life, and manages the underlying cause of the agitation. For instance, in February 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2022, it was projected that about 401,300 Australians have dementia, and this figure is anticipated to be doubled to reach 849,300 in 2058. Therefore, the increase in the incidence of dementia is driving the growth of the acute agitation and aggression treatment market.

Competitive Landscape:
Major companies operating in the acute agitation and aggression treatment market market include Pfizer Inc., Johnson and Johnson Pvt Ltd., F Hoffmann-La Roche Ltd, AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, GlaxoSmithKline plc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co Ltd., Mylan NV, Biogen Inc., Bausch Health Companies Inc., UCB SA, Servier Laboratories, Sun Pharmaceutical Industries Ltd, AstraZeneca PLC, Ono Pharmaceutical Co Ltd, Apotex Inc., H Lundbeck A/S, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Neurocrine Biosciences Inc, Aurobindo Pharma Limited, Alkermes plc., Indivior plc., Sunovion Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., and Alexza Pharmaceuticals Inc

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/acute-agitation-and-aggression-treatment-global-market-report

Top Trend - Innovative Sublingual Film Igalmi (Dexmedetomidine) Revolutionizes Acute Agitation Treatment Market
Major companies operating in the acute agitation and aggression treatment market are developing innovative products and getting approved, such as IGALMI (dexmedetomidine), to provide a new treatment option for patients with agitation associated with schizophrenia or bipolar disorder. IGALMI (dexmedetomidine) is a sublingual film used to treat acute agitation associated with schizophrenia or bipolar I or II disorder in adults. For instance, in April 2022, BioXcel Therapeutics Inc., a US-based biopharmaceutical company, received IGALMI (dexmedetomidine) approval from the Food and Drug Administration. It is a quick-acting drug that starts working in a matter of minutes. It is also a short-acting medication, with effects lasting for about 2 hours. It can significantly improve existing therapies for a severe or life-threatening condition.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Acute Agitation And Aggression Treatment Market Characteristics
3. Acute Agitation And Aggression Treatment Market Trends And Strategies
4. Acute Agitation And Aggression Treatment Market - Macro Economic Scenario
5. Acute Agitation And Aggression Treatment Market Size And Growth
…..
27. Acute Agitation And Aggression Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

"About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology."

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Agitation And Aggression Treatment Market Demand: Analysis, Outlook, and Trends 2024-2033 here

News-ID: 3395117 • Views:

More Releases from The Business research company

Veterinary Telehealth Market Drivers, Key Players, Share, Market Size And Forecast To 2033
Veterinary Telehealth Market Drivers, Key Players, Share, Market Size And Foreca …
The veterinary telehealth market size has grown rapidly in recent years. It will grow from $3.74 billion in 2023 to $4.48 billion in 2024 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to strong emerging markets growth, increased spending on pets, supportive government initiatives, and increased penetration of pet insurance.. The veterinary telehealth market size is expected to see
Thermoforming Plastic Market Size, Key Players, Trend Analysis, Growth And Forecast To 2033
Thermoforming Plastic Market Size, Key Players, Trend Analysis, Growth And Forec …
The thermoforming plastic market size has grown strongly in recent years. It will grow from $48.76 billion in 2023 to $52.13 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the increase in demand for consumer durables, a rise in concerns about hygiene and product safety, a rise in the use of thermoformed plastics in
Speaker Drivers Market Size, Share, Growth Analysis, Business Insights And Forecast To 2033
Speaker Drivers Market Size, Share, Growth Analysis, Business Insights And Forec …
The speaker drivers market size has grown strongly in recent years. It will grow from $30.35 billion in 2023 to $31.9 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to strong economic growth in emerging markets, increasing use of in-wall speaker, increasing consumer spending on entertainment and a rise in disposable income across developing countries.. The
Satellite Bus Market Growth Drivers, Strategic Analysis, Market Share, Key Trends And Forecast To 2033
Satellite Bus Market Growth Drivers, Strategic Analysis, Market Share, Key Trend …
The satellite bus market size has grown strongly in recent years. It will grow from $12.1 billion in 2023 to $12.88 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing demand for small satellites, high adoption of satellite constellation, and growing number of private space enterprises. The satellite bus market size is expected to

All 5 Releases


More Releases for Acute

Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but
Pipeline Review, H2 2017 of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic …
"Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
Acute Renal Failure (ARF) (Acute Kidney Injury) Market: Industry Size, Share, Gr …
Latest industry research report on: Acute Renal Failure (ARF) (Acute Kidney Injury) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2017, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Request For Sample Report
Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review, H2
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2017” to its report offerings. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1230595 Acute kidney failure occurs when kidneys suddenly become unable to filter waste products from blood.
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth